FRIDAY, Feb. 24, 2023 (HealthDay News) -- Neurodevelopment and growth in offspring is not negatively impacted by prenatal exposure to attention-deficit/hyperactivity disorder (ADHD) medication, according to a study published online Feb. 9 in Molecular Psychiatry.